"Designing Growth Strategies is in our DNA"

Europe Prothrombin Complex Concentrate (PCC) Market Size, Share & Covid-19 Impact Analysis, By Product (4-factor PCC and 3-factor PCC), By Application (Acquired Coagulation Deficiency and Congenital Coagulation Deficiency and By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, and Others), 2020-2027

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI104721

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Epidemiology of Coagulation Factor Deficiency – For Key Countries
    2. Recent Industry Developments – Partnerships, Mergers & Acquisitions
    3. Regulatory Scenario – For Key Countries
    4. Analysis in Relation to Alternatives to PCC
    5. PCC Market: Reimbursement Scenario & Key Industry Trends
    6. Impact of COVID-19 on Europe PCC Market
  5. Europe Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  6. U.K. Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  7. Germany Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  8. France Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  9. Italy Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  10. Spain Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  11. Scandinavia Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  12. Rest of Europe Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product - By Value (US$, Mn)
      1. 3-factor PCC
      2. 4-factor PCC
    3. Market Analysis, Insights and Forecast – By Application-By Value (US$, Mn)
      1. Acquired Coagulation Factor Deficiency
      2. Congenital Coagulation Factor Deficiency
    4. Market Analysis, Insights and Forecast – By End User - By Value (US$, Mn)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Others
  13. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))
      1. CSL Limited
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      2. Grifols SA
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      3. Octapharma AG
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      4. Sanquin
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      5. Kedrion S.p.A
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      6. Shire (Takeda Pharmaceutical Company Limited)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
      7. Other Players
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (based on availability)
  14. Strategic Recommendations
Read Less

Figure 01: Europe Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 02: Europe Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 03: Europe Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 04: Europe Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 05: Europe Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 06: Europe Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 07: Europe Prothrombin Complex Concentrate Market Value Share (US$ Million), by Country/Sub-region, 2019 & 2027

Figure 08: Europe Prothrombin Complex Concentrate Market Value Share (%), by Country/Sub-region, 2019

Figure 09: U.K. Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 10: U.K. Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 11: U.K. Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 12: U.K. Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 13: U.K. Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 14: U.K. Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 15: Germany Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 16: Germany Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 17: Germany Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 18: Germany Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 19: Germany Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 20: Germany Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 21: France Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 22: France Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 23: France Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 24: France Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 25: France Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 26: France Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 27: Italy Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 28: Italy Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 29: Italy Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 30: Italy Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 31: Italy Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 32: Italy Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 33: Spain Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 34: Spain Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 35: Spain Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 36: Spain Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 37: Spain Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 38: Spain Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 39: Scandinavia Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 40: Scandinavia Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 41: Scandinavia Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 42: Scandinavia Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 43: Scandinavia Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 44: Scandinavia Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 45: Rest of Europe Prothrombin Complex Concentrate Market Value Share (US$ Million), by Product, 2019 & 2027

Figure 46: Rest of Europe Prothrombin Complex Concentrate Market Value Share (%), by Product, 2019

Figure 47: Rest of Europe Prothrombin Complex Concentrate Market Value Share (US$ Million), by Application, 2019 & 2027

Figure 48: Rest of Europe Prothrombin Complex Concentrate Market Value Share (%), by Application, 2019

Figure 49: Rest of Europe Prothrombin Complex Concentrate Market Value Share (US$ Million), by End User, 2019 & 2027

Figure 50: Rest of Europe Prothrombin Complex Concentrate Market Value Share (%), by End User, 2019

Figure 51: Global PCC Market Share Analysis (%), By Company, 2019

Table 01: Europe Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product, 2016–2027

Table 02: Europe Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 03: Europe Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Table 04: Europe Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Country/Sub-region, 2016–2027

Table 05: U.K. Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product, 2016–2027

Table 06: U.K. Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 07: U.K. Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Table 08: Germany Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product, 2016–2027

Table 09: Germany Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 10: Germany Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Table 11: France Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product, 2016–2027

Table 12: France Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 13: France Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Table 14: Italy Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product

Table 15: Italy Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 16: Italy Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Table 17: Spain Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product, 2016–2027

Table 18: Spain Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 19: Spain Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Table 20: Scandinavia Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product, 2016-2027

Table 21: Scandinavia Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 22: Scandinavia Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Table 23: Rest of Europe Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Product, 2016–2027

Table 24: Rest of Europe Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by Application, 2016–2027

Table 25: Rest of Europe Prothrombin Complex Concentrate Market Revenue (US$ Million) Forecast, by End User, 2016–2027

Europe Prothrombin Complex Concentrate (PCC) Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?